Understanding how the brain processes fear and safety signals
Encoding of fear and safety discrimination in prefrontal-amygdala projections
['FUNDING_CAREER'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-10885966
This study is looking at how certain parts of the brain help us tell the difference between feeling scared and feeling safe, which is really important for people dealing with anxiety or PTSD, and it could help find new ways to treat these conditions.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-10885966 on ClinicalTrials.gov |
What this research studies
This research investigates the brain mechanisms involved in distinguishing between fear and safety, which is crucial for understanding anxiety disorders and PTSD. The project focuses on the medial prefrontal cortex and the basolateral amygdala, two key areas of the brain that help process these signals. Through advanced techniques, the researchers aim to identify how specific receptors in these brain regions influence fear responses and safety perceptions. This work could lead to new treatments for anxiety disorders by targeting these neural pathways.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who experience anxiety disorders or PTSD.
Not a fit: Patients with non-anxiety-related mental health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for anxiety disorders and PTSD, enhancing patients' quality of life.
How similar studies have performed: Previous research has shown promising results in understanding the neurophysiology of fear and safety, suggesting that this approach could yield significant insights.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: STUJENSKE, JOSEPH MATTHEW — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: STUJENSKE, JOSEPH MATTHEW
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.